[Retracted] Clinical Application of Anlotinib Combined with Docetaxel: Safe and Effective Treatment for Lung Carcinoma

Table 2

Comparison of clinical efficacy between the two groups (%).

Group	Number of patients	CR	PR	SD	PD	Overall effectiveness
Control group	42	0 (0.00)	7 (16.67)	22 (52.38)	13 (30.95)	7 (16.67)
Experimental group	42	4 (9.52)	20 (47.62)	11 (26.19)	7 (16.67)	24 (57.18)
	—	14.775
	—	<0.001